What is Lifebit?
Headquartered in London, Lifebit provides a sophisticated, federated ecosystem designed to streamline the analysis of sensitive biomedical data. Its flagship product, Lifebit CloudOS, offers a secure environment for FAIR (Findable, Accessible, Interoperable, Reusable) omics analysis, effectively removing the traditional barriers associated with data silos. Complementing this, the Lifebit AI-Engine utilizes deep learning to interpret biological responses, providing pharmaceutical enterprises with the tools necessary for drug repurposing, target validation, and vaccine optimization. By enabling researchers to reason about complex datasets with human-like precision, Lifebit is fundamentally transforming how life sciences organizations approach large-scale data environments.
How much funding has Lifebit raised?
Lifebit has raised a total of $70.5M across 3 funding rounds:
Angel/Seed
$3M
Series A
$7.5M
Series B
$60M
Angel/Seed (2018): $3M, investors not publicly disclosed
Series A (2020): $7.5M led by Beacon Capital Partners , LLC, Connect Ventures, Idinvest Partners, and Pentech Ventures LLP
Series B (2021): $60M supported by Tiger Global Management, Beacon Capital Partners, Eurazeo, and Pentech Ventures
Key Investors in Lifebit
Tiger Global Management
Tiger Global Management is a prominent investment firm that deploys significant capital across both public and private markets, focusing on high-growth technology companies.
Eurazeo
Headquartered in Paris, Eurazeo is a leading global investment company providing deep sector expertise and a stable foothold for transformational growth across private equity and venture capital.
Idinvest Partners
Idinvest Partners is a mid-market private equity firm that specializes in financing and supporting entrepreneurs throughout various stages of their business development.
What's next for Lifebit?
With this latest infusion of capital, Lifebit is well-positioned to expand its global footprint and enhance its AI-driven research capabilities. The strategic focus will likely center on deepening the integration of its CloudOS within major pharmaceutical pipelines, further automating the drug discovery process. As the company scales, it is expected to prioritize the development of new analytical modules that address emerging challenges in precision medicine and genomic research. By maintaining its commitment to secure, federated data access, Lifebit is set to remain at the forefront of the digital transformation in healthcare, providing the essential infrastructure for the next generation of biomedical breakthroughs.
See full Lifebit company page
